Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?
Christianne Groeneveldt, Jasper van den Ende, Nadine van Montfoort
Cytokine & Growth Factor Reviews (2023) Vol. 70, pp. 1-12
Open Access | Times Cited: 24

Showing 24 citing articles:

Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
Palaniyandi Muthukutty, So Young Yoo
Viruses (2023) Vol. 15, Iss. 8, pp. 1645-1645
Open Access | Times Cited: 23
Synergistic Viro-chemoimmunotherapy in Breast Cancer Enabled by Bioengineered Immunostimulatory Exosomes and Dual-Targeted Coxsackievirus B3
Amirhossein Bahreyni, Yasir Mohamud, Sanaz Ashraf Nouhegar, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4241-4255
Open Access | Times Cited: 11
Oncolytic viral therapy for gliomas: Advances in the mechanisms and approaches to delivery
Alexander Romanishin, A. Yu. Vasil’ev, E Khasanshin, et al.
Virology (2024) Vol. 593, pp. 110033-110033
Closed Access | Times Cited: 8
Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
Yan Zhuo, Zhengbo Zhang, Yanan Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Chimeric Ad5/35 oncolytic adenovirus overcome preexisting neutralizing antibodies and enhance tumor targeting efficiency
Zhou‐Tong Dai, Yao Si, S. Xiong, et al.
Cancer Gene Therapy (2025)
Closed Access
Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients
Syed Mohd Faisal, María G. Castro, Pedro R. Löwenstein
Molecular Therapy (2023) Vol. 31, Iss. 10, pp. 2839-2860
Open Access | Times Cited: 9
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses
Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu, et al.
(2024)
Open Access | Times Cited: 2
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses
Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9912-9912
Open Access | Times Cited: 2
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 3, pp. 334-349
Open Access | Times Cited: 1
Tuning Cellular Metabolism for Cancer Virotherapy
Dian Xiong, Qing Wang, Weiming Wang, et al.
Cancer Letters (2024) Vol. 592, pp. 216924-216924
Closed Access | Times Cited: 1
Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus
Guiomar Casado-Fernández, Juan Cantón, Laura Nasarre, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
The investigation of oncolytic viruses in the field of cancer therapy
Zijun Yuan, Yinping Zhang, Xiang Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Virus nanotechnology for intratumoural immunotherapy
Anthony O. Omole, Zhongchao Zhao, Sabrina Chang-Liao, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 916-929
Closed Access | Times Cited: 1
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients
Vincenzo Raimondi, Rosanna Vescovini, M. Dessena, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
Elise Jirovec, Dafne C.A. Quixabeira, James H.A. Clubb, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Modeling of oncolytic viruses in a heterogeneous cell population to predict spread into non-cancerous cells
Karan Buntval, Hana M. Dobrovolny
Computers in Biology and Medicine (2023) Vol. 165, pp. 107362-107362
Open Access | Times Cited: 3
Chimeric oncolytic adenovirus to break away from neutralizing antibodies
Judit Sánchez Gil, Hirotaka Fudaba, Hiroaki Wakimoto
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 875-877
Closed Access
Mesenchymal stromal cells protect combined oncolytic and helper-dependent adenoviruses from humoral immunity
Ada I Ozcan, Arianexys Aquino Lόpez, A Wolff, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101279-101279
Open Access
A Dual-Armed Oncolytic Virus Shows Clinical Efficacy in Advanced Solid Cancers
Noelia Silva-Pilipich, Cristian Smerdou
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3649-3651
Closed Access
Revolutionizing Cancer Treatment: Unleashing the Power of Combining Oncolytic Viruses with CAR-T Cells
Zhang Lin, Shuxian Guo, ShuYing Chang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1407-1418
Closed Access
Clinical and Translational Landscape of Viral Gene Therapies
Alexandra Yudaeva, Anastasiya Kostyusheva, Artyom Kachanov, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1916-1916
Open Access
Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response
Haoran Zhu, Wanrong Zhang, Qingguo Guo, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009901-e009901
Open Access
Channeling the Natural Properties of Sindbis Alphavirus for Targeted Tumor Therapy
Christine Pampeno, Alicia Hurtado, Silvana Opp, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14948-14948
Open Access | Times Cited: 1
Page 1

Scroll to top